Current Value
$13.931 Year Return
Current Value
$13.931 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -26.54% | $184.73M | 0.85% |
TAIL | -25.90% | $94.86M | 0.59% |
BTAL | -18.01% | $315.93M | 1.43% |
PSQA | -11.06% | $36.49M | 0.2% |
IVOL | -10.98% | $342.69M | 1.02% |
OWNS | -10.04% | $128.37M | 0.3% |
XONE | -9.73% | $628.85M | 0.03% |
SPTS | -8.95% | $5.77B | 0.03% |
UNG | -8.79% | $375.27M | 1.06% |
FXY | -8.57% | $802.69M | 0.4% |
TFLO | -8.37% | $6.74B | 0.15% |
JMST | -8.30% | $4.09B | 0.18% |
BIL | -8.25% | $41.93B | 0.1356% |
ULST | -8.14% | $592.38M | 0.2% |
STOT | -8.05% | $252.82M | 0.45% |
CARY | -7.84% | $347.36M | 0.8% |
IBTG | -7.33% | $1.92B | 0.07% |
UTWO | -7.07% | $376.33M | 0.15% |
SGOV | -7.06% | $50.93B | 0.09% |
BILS | -6.92% | $3.80B | 0.1356% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PZA | -0.01% | $2.83B | 0.28% |
VGLT | 0.01% | $9.59B | 0.04% |
BSCQ | -0.01% | $4.25B | 0.1% |
MBB | 0.05% | $38.92B | 0.04% |
LMBS | 0.08% | $5.11B | 0.64% |
SPTL | -0.08% | $11.17B | 0.03% |
ISTB | 0.10% | $4.41B | 0.06% |
MTBA | -0.16% | $1.37B | 0.17% |
FMHI | 0.25% | $746.85M | 0.7% |
YEAR | -0.26% | $1.46B | 0.25% |
CERY | -0.30% | $482.30M | 0.28% |
TLH | -0.30% | $11.30B | 0.15% |
SCHQ | -0.37% | $779.81M | 0.03% |
TBIL | 0.38% | $5.76B | 0.15% |
UITB | 0.43% | $2.33B | 0.39% |
SPMB | -0.44% | $6.15B | 0.04% |
WEAT | 0.46% | $123.28M | 0.28% |
PDBC | 0.50% | $4.52B | 0.59% |
TOTL | 0.54% | $3.80B | 0.55% |
SPAB | 0.55% | $8.76B | 0.03% |
Yahoo
MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO), today announced the promotion of Laura Sandler to Chief Operating Officer. Ms. Sandler, who joined Oruka in 2024 as SVP of Operations, brings over 20 years of biopharmaceutical leadership experience across clinical operat
Finnhub
Oruka Therapeutics, Inc. added to Russell 3000 Value Index...
Finnhub
Oruka Therapeutics, Inc. added to Russell 2500 Value Index...
Finnhub
Oruka Therapeutics, Inc. added to Russell 2000 Dynamic Index...
Finnhub
Oruka Therapeutics, Inc. dropped from Russell Microcap Growth Index...
Finnhub
Oruka Therapeutics, Inc. added to Russell Small Cap Comp Value Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PM | 0.03% | $281.71B | +72.37% | 3.01% |
PARAA | -0.09% | $15.51B | +7.37% | 0.87% |
KLG | 0.15% | $1.97B | +42.70% | 2.84% |
CCRN | 0.18% | $408.48M | -8.25% | 0.00% |
NAT | -0.23% | $575.96M | -28.04% | 10.64% |
BROS | -0.28% | $8.09B | +58.96% | 0.00% |
PINC | -0.28% | $1.77B | +13.85% | 3.92% |
CVS | 0.35% | $83.01B | +12.73% | 4.09% |
FRO | -0.36% | $4.11B | -21.02% | 7.21% |
FATBB | -0.39% | $47.76M | -9.82% | 10.45% |
MO | 0.41% | $98.62B | +24.36% | 7.00% |
STG | -0.41% | $38.79M | -3.01% | 0.00% |
DHT | 0.51% | $1.77B | +1.75% | 7.32% |
PRVA | -0.59% | $2.57B | +17.75% | 0.00% |
SATS | 0.60% | $9.23B | +69.61% | 0.00% |
LRN | -0.62% | $5.92B | +101.30% | 0.00% |
UNF | 0.73% | $3.11B | +2.13% | 0.79% |
NTGR | 0.78% | $845.66M | +97.85% | 0.00% |
NOC | -0.78% | $73.96B | +18.95% | 1.66% |
DFDV | -0.86% | $363.21M | +2,422.23% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SYRE | 43.66% | $963.24M | -43.26% | 0.00% |
DYN | 40.10% | $1.25B | -79.03% | 0.00% |
CRNX | 37.30% | $3.00B | -39.42% | 0.00% |
IDYA | 37.08% | $2.00B | -42.45% | 0.00% |
XNCR | 36.13% | $660.47M | -52.14% | 0.00% |
RXRX | 36.06% | $2.47B | -25.59% | 0.00% |
EYPT | 35.68% | $761.06M | +11.60% | 0.00% |
COGT | 35.33% | $1.24B | +18.71% | 0.00% |
NUVL | 34.16% | $5.89B | +5.23% | 0.00% |
APGE | 34.09% | $2.30B | -16.02% | 0.00% |
IMNM | 34.06% | $778.76M | -31.05% | 0.00% |
ZNTL | 33.82% | $98.57M | -65.58% | 0.00% |
XENE | 33.74% | $2.53B | -19.91% | 0.00% |
IGMS | 33.74% | $81.76M | -85.38% | 0.00% |
APLS | 33.73% | $2.45B | -49.78% | 0.00% |
ATXS | 33.69% | $376.42M | -40.71% | 0.00% |
REPL | 33.19% | $830.22M | +8.57% | 0.00% |
MRSN | 33.03% | $47.36M | -81.28% | 0.00% |
KYMR | 33.01% | $3.17B | +15.92% | 0.00% |
SGML | 32.94% | $626.52M | -53.66% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 44.36% | $4.81B | 0.35% |
IBB | 40.07% | $5.37B | 0.45% |
GNOM | 38.73% | $46.47M | 0.5% |
PBE | 38.25% | $226.91M | 0.58% |
BBH | 36.76% | $339.54M | 0.35% |
PTH | 34.90% | $96.25M | 0.6% |
ARKG | 34.72% | $1.03B | 0.75% |
PINK | 34.11% | $130.30M | 0.5% |
IWC | 33.71% | $840.86M | 0.6% |
RDTE | 32.75% | $139.04M | 0.97% |
XPH | 32.67% | $150.58M | 0.35% |
IWO | 32.45% | $11.77B | 0.24% |
BKCH | 32.24% | $188.81M | 0.5% |
KOMP | 32.13% | $2.34B | 0.2% |
HEQT | 32.07% | $328.60M | 0.44% |
FINX | 31.88% | $311.04M | 0.68% |
FBT | 31.78% | $1.02B | 0.54% |
HFND | 31.46% | $27.57M | 1.07% |
QTUM | 31.21% | $1.68B | 0.4% |
IPAY | 30.80% | $291.58M | 0.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DG | -28.50% | $24.71B | -14.69% | 2.10% |
AGL | -14.33% | $956.23M | -62.44% | 0.00% |
WBA | -10.77% | $10.01B | +1.14% | 4.34% |
DLTR | -10.56% | $22.62B | +1.54% | 0.00% |
CORT | -10.10% | $7.64B | +131.02% | 0.00% |
KR | -10.04% | $46.75B | +34.05% | 1.81% |
OOMA | -9.21% | $346.93M | +27.48% | 0.00% |
VSTA | -9.09% | $325.62M | +30.97% | 0.00% |
BJ | -8.46% | $14.09B | +17.71% | 0.00% |
CNC | -8.42% | $16.18B | -51.64% | 0.00% |
BIRK | -7.19% | $8.98B | -12.76% | 0.00% |
LITB | -6.48% | $24.26M | -71.62% | 0.00% |
OXBR | -6.42% | $16.75M | -10.00% | 0.00% |
HUSA | -5.97% | $20.99M | -8.33% | 0.00% |
VHC | -5.12% | $69.05M | +176.10% | 0.00% |
CABO | -4.98% | $746.86M | -60.59% | 6.76% |
PRT | -4.88% | $48.30M | +1.02% | 11.00% |
LFVN | -4.84% | $155.72M | +105.82% | 1.34% |
K | -4.79% | $27.64B | +40.17% | 2.86% |
CBOE | -4.43% | $24.55B | +38.09% | 1.08% |